Drug Type Monoclonal antibody |
Synonyms Immunereszumab, IR-1000 |
Target |
Mechanism IL-1β modulators(Interleukin-1 beta modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | US | - |